Pharmaceutical Tariffs Explained: The Will-They-Won’t-They Story of 2025

Health Affairs' Jeff Byers welcomes
Stacie Dusetzina of Vanderbilt
University Medical Center and David
Simon of the University of Connecticut back to the pod
to the current state of drug prices, how proposed tariffs may
impact the pharmaceutical industry, that Pfizer deal, what
consumers can expect if tariffs are added to prescription drugs,
what exactly TrumpRx is, and more.


Become an Insider today to get access to our third trend report
focusing on the influence of private equity in health
care.


Related Articles:


Trump admin readies 'imminent' probe into other nations' drug
pricing, raising new tariff threat: FT (FiercePharma)

President Trump’s Executive Orders On Prescription Drug
Prices: What The Evidence Says (Health Affairs Forefront)